Lung Diseases, Interstitial, Pulmonary Disease, Chronic Obstructive
Conditions
Keywords
walking speed, dyspnoe, stress, anxiety, traffic light
Brief summary
The aim of this study is to evaluate the effects of a three-week inpatient pulmonary rehabilitation (PR) program on the walking speed in patients with chronic obstructive (COPD) or interstitial lung disease (ILD).
Detailed description
At most german traffic light crossings, a walking speed of 1,2m/sec is required to cross the road in time. Patients who are unable to cross the road at this speed, expose themselves to an increased level of stress and possibly the risk of accidents. Thus, they are discouraged from participating in an active social life. An UK study (Nolan et al., Thorax 2018) showed that only 10.7% of the 926 patients with moderate COPD attained a walking speed of 1.2m/sec. As PR plays a key role in the management of chronic lung diseases in order to improve patients´ exercise capacity, the aim of this study was to evaluate the PR effects on the Walking Speed in patients with COPD or ILD. The investigators hypothesize that PR improves the ability to cross the road in the appropriate time.
Interventions
None listed
Sponsors
Psychologische Hochschule Berlin
Schön Klinik Berchtesgadener Land
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
40 Years to 85 Years
Healthy volunteers
No
Inclusion criteria
* Participation in a pulmonary Rehabilitation program (Schön Klinik BGL) * Indication: COPD or ILD * COPD; FEV1 \<50% * ILD: FVC \<70% * written informed consent
Exclusion criteria
* non compliance
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| change of maximum walking speed | Day 1 and Day 21 | assessed during a walk of 11m |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in balance | Day 1 and Day 21 | measured by the Leonardo platform |
| Change in walking speed during a field walk test | Day 1 and Day 21 | measured by the time needed to cross a traffic light (distance: 11m) |
| Change in tension symptoms during a field walk test | Day 1 and Day 21 | intensity of perceived tension symptoms experienced when crossing a traffic light (VAS scale, ranging from 0 to 10) |
| Change of exercise capacity | Day 1 and Day 21 | measured by the sit-to-stand test, test duration: 1 minute |
| Change in maximum leg strength | Day 1 and Day 21 | measured by the microfet, knee Extension |
| Change of usual walking Speed | Day 1 and Day 21 | assessed during a walk of 11m by using the individual daily life Walking Speed. |
| Change of frailty (FFP) | Day 1 and Day 21 | measured by Fried Frailty Phenotype (FFP), including five constructs (weight loss, exhaustion, physical activity, gait speed and weakness); range 0-5, higher scores reflect increased Frailty: A score of 0 is considered as robust, a score of 1-2 is considered as pre-frail, a score lower than 2 reflects Frailty |
| Change in Quality of life: Chronic Respiratory Disease Questionnaire (CRQ) | Day 1 and Day 21 | assessed by the Chronic Respiratory Disease Questionnaire (CRQ)- a 20-item self-report questionnaire; score 1-7; higher scores indicate a better health-related quality of life |
| Change in illness perception | Day 1 and Day 21 | assessed by the Illness perception Questionnaire, revised (IPQ-R) - 18 items, score 1-5; higher scores indicate a worse illness perception, except of item 7,9,10,11,12. |
| Change in COPD-related fears on disease-specific disability | Day 1 and Day 21 | assessed by the German COPD Angst Fragebogen (CAF) - a 20-item self-report questionnaire, rated on a Lickert-scale (score 0-4); highest maximum score: 80 points; higher scores indicate higher anxiety levels. |
| Change in anxiety and Depression symptoms | Day 1 and Day 21 | Anxiety/Depression measured by Hospital Anxiety and Depression Scale (HADS) - a screening questionnaire including seven questions each about Depression and Anxiety; each part ranging from 0 to 21; higher scores indicate higher presence of the respective state |
Countries
Germany
Contacts
Primary ContactKlaus Kenn, Prof.
Backup ContactInga Jarosch, PhD
Outcome results
None listed